Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.4950 (2.35%) ($8.4950 - $8.5100) on Wed. Apr. 5, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.27% (three month average) | RSI | 59 | Latest Price | $8.4950(2.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(29%) CEMB(23%) BWX(21%) VWO(21%) XLRE(21%) | Factors Impacting BCRX price | BCRX will decline at least -1.635% in a week (0% probabilities). VIXM(-20%) VXX(-17%) UUP(-12%) TLT(-10%) VCIT(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.635% (StdDev 3.27%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.38(1.37%) | 10 Day Moving Average | $8.42(0.89%) | 20 Day Moving Average | $8.31(2.23%) | To recent high | -28.3% | To recent low | 7.1% | Market Cap | $1.499b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |